Literature DB >> 23733968

Evolution and emergence of therapeutic monoclonal antibodies: what cardiologists need to know.

Ian N Foltz1, Margaret Karow, Scott M Wasserman.   

Abstract

Keywords:  Pcsk9 protein; antibodies, monoclonal; heart diseases; hypercholesterolemia

Mesh：

Substances：

Year:  2013        PMID： 23733968     DOI： 10.1161/CIRCULATIONAHA.113.002033

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  31 in total

Review 1.  The evolution of domain arrangements in proteins and interaction networks.

Authors:  E Bornberg-Bauer; F Beaussart; S K Kummerfeld; S A Teichmann; J Weiner
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

2.  Targeting inflammatory pathways for the treatment of cardiovascular disease.

Authors:  Paul M Ridker
Journal:  Eur Heart J       Date:  2013-11-07       Impact factor: 29.983

3.  Health security preparedness and industry trends.

Authors:  Stanley T Crooke
Journal:  Health Secur       Date:  2015-03-16

4.  A minimal physiologically based pharmacokinetic model to investigate FcRn-mediated monoclonal antibody salvage: Effects of Kon, Koff, endosome trafficking, and animal species.

Authors:  Brian M Maas; Yanguang Cao
Journal:  MAbs       Date:  2018-09-11       Impact factor: 5.857

Review 5.  Evolocumab: Considerations for the Management of Hyperlipidemia.

Authors:  Barbara S Wiggins; Jeffrey Senfield; Helina Kassahun; Armando Lira; Ransi Somaratne
Journal:  Curr Atheroscler Rep       Date:  2018-03-06       Impact factor: 5.113

Review 6.  Neurological Complications of Therapeutic Monoclonal Antibodies: Trends from Oncology to Rheumatology.

Authors:  Chandler Gill; Stasia Rouse; Ryan D Jacobson
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-17       Impact factor: 5.081

Review 7.  Targeting CGRP: A New Era for Migraine Treatment.

Authors:  Stephanie Wrobel Goldberg; Stephen David Silberstein
Journal:  CNS Drugs       Date:  2015-06       Impact factor: 5.749

Review 8.  [PCSK9 inhibitors in hypercholesterolemia. New hope for patients with diabetes mellitus?].

Authors:  K G Parhofer
Journal:  Herz       Date:  2016-05       Impact factor: 1.443

Review 9.  MERS-CoV spike protein: a key target for antivirals.

Authors:  Lanying Du; Yang Yang; Yusen Zhou; Lu Lu; Fang Li; Shibo Jiang
Journal:  Expert Opin Ther Targets       Date:  2016-12-21       Impact factor: 6.902

10.  Research and development of therapeutic mAbs: An analysis based on pipeline projects.

Authors:  Xiaomei Geng; Xiangjun Kong; Hao Hu; Jiayu Chen; Fengqing Yang; Hongyu Liang; Xin Chen; Yuanjia Hu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.